Previous Close | 2.9500 |
Open | 3.1300 |
Bid | 0.0000 x 1200 |
Ask | 0.0000 x 1000 |
Day's Range | 2.5700 - 3.1300 |
52 Week Range | 1.0200 - 3.1900 |
Volume | |
Avg. Volume | 162,636 |
Market Cap | 50.956M |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | -2.2000 |
Earnings Date | Nov 20, 2023 - Nov 24, 2023 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 6.50 |
Subscribe to Yahoo Finance Plus to view Fair Value for DERM
Journey Medical Corporation ( NASDAQ:DERM ) insiders who bought shares over the past year were rewarded handsomely last...
On September 6, 2023, Claude Maraoui, President & CEO of Journey Medical Corp (NASDAQ:DERM), made a significant insider purchase of 26,044 shares of the company's stock.
Journey Medical (DERM) enters into a second licensing agreement with Maruho to develop and commercialize Qbrexza to treat hyperhidrosis in certain Asian countries. The stock surges 18.4%.